Skip to main content

Table 3 Five-year relative survival of breast cancer patients by age and stage

From: Trends of population-based breast cancer survival in Germany and the US: Decreasing discrepancies, but persistent survival gap of elderly patients in Germany

stage Germany (Saarland) US (SEER 9/13 regionsa)
   1993-96 1997-00 2001-04 2005-08 Δ p-value 1993-96 1997-00 2001-04 2005-08 Δ p-value
   RS SE RS SE RS SE RS SE    RS SE RS SE RS SE RS SE   
overall crude 73.0 1.1 77.1 1.0 80.1 0.9 84.2 0.9 11.2 <0.001 84.1 0.2 86.3 0.2 88.2 0.1 88.6 0.1 4.5 <0.001
  age std b 72.2 1.3 76.3 1.2 79.0 1.1 82.5 1.0 10.3 <0.001 84.2 0.2 86.3 0.2 88.2 0.2 88.1 0.2 3.9 <0.001
  stage mix std c 78.8 1.1 82.3 0.9 85.3 0.8 87.9 0.7 9.1 <0.001 84.1 0.2 85.7 0.1 87.7 0.1 88.1 0.1 4.0 <0.001
  15-49 years 75.4 2.0 78.6 1.8 83.9 1.6 87.7 1.4 12.3 <0.001 82.8 0.3 85.2 0.3 87.3 0.2 89.2 0.2 6.4 <0.001
  50-69 years 74.7 1.4 79.1 1.3 81.7 1.1 88.6 1.0 14.0 <0.001 85.4 0.2 87.5 0.2 89.8 0.2 90.0 0.2 4.7 <0.001
  15-69 years 74.9 1.2 78.9 1.0 82.3 0.9 88.4 0.8 13.5 <0.001 84.4 0.2 86.7 0.2 88.9 0.1 89.7 0.1 5.3 <0.001
  > = 70 years 69.3 2.4 73.6 2.2 75.1 2.1 74.9 2.1 5.6 0.026 83.6 0.4 85.5 0.4 86.5 0.4 85.7 0.4 2.1 0.001
localized crude 90.7 1.5 93.3 1.2 96.0 1.0 97.5 0.9 6.8 0.002 95.4 0.2 96.1 0.2 97.0 0.2 97.2 0.1 1.8 <0.001
  age std b 91.4 2.4 94.5 1.9 97.4 1.6 98.7 1.4 7.3 <0.001 95.7 0.2 96.3 0.2 97.3 0.2 97.3 0.2 1.6 <0.001
  15-49 years 86.9 2.5 92.3 1.9 93.1 1.6 95.3 1.4 8.4 0.011 93.6 0.3 94.1 0.2 95.4 0.2 96.3 0.2 2.7 <0.001
  50-69 years 91.7 1.8 91.6 1.5 95.4 1.2 98.7 0.9 7.0 0.001 95.4 0.2 96.4 0.2 97.4 0.2 97.6 0.2 2.2 <0.001
  15-69 years 90.1 1.5 91.8 1.2 94.7 0.9 97.8 0.7 7.7 <0.001 94.8 0.2 95.6 0.1 96.8 0.1 97.2 0.1 2.4 <0.001
  > = 70 years 93.2 4.6 98.3 3.5 99.9 2.9 96.6 2.9 3.4 0.555 96.7 0.5 97.0 0.4 97.5 0.4 97.4 0.4 0.7 0.290
  T1 age std b 97.3 4.0 99.3 2.9 99.5 2.4 104.1 1.8 6.8 - 98.8 0.3 99.5 0.2 99.9 0.2 100.4 0.2 1.7 -
  T2-3 age std b 89.4 3.7 92.1 2.9 93.9 2.4 92.1 2.4 2.7 0.110 86.3 0.6 87.0 0.5 89.7 0.5 89.3 0.5 3.0 <0.001
local/regional spread crude 65.2 1.8 70.9 1.7 76.4 1.5 81.1 1.5 15.9 <0.001 75.8 0.4 79.0 0.3 83.3 0.3 85.0 0.3 9.2 <0.001
  age std b 64.0 2.2 70.3 2.0 74.8 1.9 78.6 1.8 14.6 <0.001 75.1 0.4 77.5 0.4 81.7 0.4 82.8 0.4 7.6 <0.001
  15-49 years 70.7 3.4 71.4 3.1 81.1 2.7 82.6 2.6 11.9 0.004 75.5 0.6 80.2 0.5 83.5 0.4 86.8 0.4 11.3 <0.001
  50-69 years 65.3 2.5 72.2 2.2 77.6 1.9 86.2 1.7 20.8 <0.001 78.1 0.5 80.6 0.4 86.3 0.3 87.1 0.3 9.1 <0.001
  15-69 years 66.9 2.0 71.9 1.8 78.6 1.6 85.1 1.4 18.2 <0.001 76.9 0.4 80.4 0.3 85.2 0.3 87.0 0.2 10.0 <0.001
  > = 70 years 61.1 4.0 68.7 3.7 70.5 3.7 70.8 3.6 9.7 0.084 72.4 0.9 74.3 0.8 76.7 0.8 77.5 0.8 5.1 <0.001
  T1/2 age std b 73.0 3.1 79.3 2.7 84.4 2.4 85.6 2.2 12.6 <0.001 81.4 0.5 83.6 0.5 87.7 0.4 88.1 0.4 6.7 <0.001
  T3/4 age std b 47.1 3.6 52.3 3.5 56.2 3.4 64.3 3.2 17.2 <0.001 64.3 1.0 68.1 0.9 71.7 0.8 68.8 0.8 4.5 0.001
distant metastasis crude 20.2 3.0 21.9 3.0 20.1 2.6 23.0 3.0 2.8 0.111 21.2 0.7 24.1 0.7 27.2 0.7 29.2 0.7 7.9 <0.001
  age std b 20.3 3.2 22.1 3.0 19.0 2.6 23.7 3.0 3.3 0.106 20.2 0.7 22.5 0.7 25.2 0.7 26.7 0.7 6.5 <0.001
  15-49 years 11.5 5.8 17.9 8.9 26.9 7.6 29.6 9.1 18.2 0.029 26.8 1.5 31.5 1.4 34.5 1.4 38.8 1.4 11.9 <0.001
  50-69 years 25.3 4.4 24.7 4.4 23.6 4.0 29.1 4.6 3.8 0.237 21.3 1.0 24.4 1.0 29.0 1.0 30.5 1.0 9.2 <0.001
  15-69 years 22.0 3.7 23.9 3.9 24.5 3.5 28.5 4.1 6.5 0.058 23.2 0.9 26.9 0.8 30.9 0.8 33.2 0.8 10.0 <0.001
  > = 70 years 17.2 5.9 19.3 4.7 13.3 3.7 15.3 4.2 −1.9 0.712 17.4 1.1 18.2 1.1 19.0 1.1 19.4 1.1 2.1 0.045
unknown stage crude 78.4 2.5 81.3 2.8 77.0 3.5 81.4 2.8 3.0 0.381 55.2 1.2 57.7 1.2 55.0 1.4 43.5 1.5 −11.7 <0.001
  age std b 78.7 2.5 82.1 2.7 77.6 3.2 82.7 2.5 4.0 0.084 55.6 1.3 59.0 1.2 56.1 1.5 45.2 1.6 −10.4 <0.001
  1. Five-year relative survival of female patients with invasive breast cancer (ICD-10 code: C50) from Germany (Saarland) and the US (SEER 9/13 regions) by age and stage for successive calendar periods.
  2. RS: relative survival (period estimate) in %; SE: standard error; std: standardized; Δ : difference of RS between 2005–08 and 1993–96 in % units; a the coverage of SEER program was extended from 9 to 13 registries in 1992; b using weights from the International Cancer Survival Standards [33]; c weights derived from the SEER patients diagnosed 1988–2008.